Ningbo Solartron Technology (688299.SH) plans to increase its investment in Zhonggu Shidai by 5 million yuan. It is focused on the field of solid-state energy storage batteries.
Changyang Technology (stock code 688299.SH) announced that the company recently signed a capital increase agreement with Zhonggu Era (Beijing) New Energy Technology Co., Ltd. (referred to as "Zhonggu Era"). The company will invest 5 million yuan with its own funds, subscribe to a new registered capital of 213,000 yuan for Zhonggu Era, and will hold 1.6667% of its equity after the capital increase is completed.
Ningbo Solartron Technology (688299.SH) announced that it has recently signed a capital increase agreement with Zhonggu Era (Beijing) New Energy Technology Co., Ltd. (referred to as "Zhonggu Era"). The company will invest 5 million yuan from its own funds to subscribe for an additional registered capital of 213,000 yuan for Zhonggu Era, and will hold 1.6667% of its equity after the capital increase.
Zhonggu Era focuses on the field of solid-state energy storage batteries, and the two parties are expected to form synergies in material verification, joint development, and supply chain integration of products such as solid-state electrolyte composite framework membranes through this external investment.
Related Articles

In the first four months of this year, the number of initial consultations for infertility at JXR (01951) increased by 7.5% year-on-year, while the number of egg retrieval cycles increased by 5.2% year-on-year.

Hainan Huluwa Pharmaceutical Group (605199.SH): Pediatric Lung Heat Cough and Asthma Granules are intended to be selected in the fourth batch of the national centralized volume procurement alliance for traditional Chinese medicine.

GME Group (08188) subsidiary granted a HKD 50 million revolving loan and import invoice financing limit.
In the first four months of this year, the number of initial consultations for infertility at JXR (01951) increased by 7.5% year-on-year, while the number of egg retrieval cycles increased by 5.2% year-on-year.

Hainan Huluwa Pharmaceutical Group (605199.SH): Pediatric Lung Heat Cough and Asthma Granules are intended to be selected in the fourth batch of the national centralized volume procurement alliance for traditional Chinese medicine.

GME Group (08188) subsidiary granted a HKD 50 million revolving loan and import invoice financing limit.






